Caris Life Sciences (CAI) Current Assets (2024 - 2026)

Caris Life Sciences' Current Assets history runs 3 years deep, the most recent figure standing at $1.0 billion for Q1 2026.

• In Q1 2026, Current Assets changed N/A year-over-year to $1.0 billion; the TTM figure through Mar 2026 stood at $1.0 billion (changed N/A YoY), while the FY2025 annual figure was $997.8 million, up 362.52% from the prior year.
• Current Assets was $1.0 billion for Q1 2026 at Caris Life Sciences, up from $997.8 million in the prior quarter.
• In the past five years, Current Assets ranged from a high of $1.0 billion in Q1 2026 to a low of $215.7 million in Q4 2024.
• Historically, Current Assets has averaged $783.1 million across 3 years, with a median of $854.2 million in 2025.
• Biggest YoY gain for Current Assets was 362.52% in 2025; the steepest drop was 362.52% in 2025.
• A 3-year view of Current Assets shows it stood at $215.7 million in 2024, then surged by 362.52% to $997.8 million in 2025, then climbed by 1.64% to $1.0 billion in 2026.
• The last three Current Assets figures came in at $1.0 billion (Q1 2026), $997.8 million (Q4 2025), and $854.2 million (Q3 2025), per Business Quant data.